Cadian Capital Management, LP Maxcyte, Inc. Transaction History
Cadian Capital Management, LP
- $1.72 Billion
- Q4 2024
A detailed history of Cadian Capital Management, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 9,344,424 shares of MXCT stock, worth $37 Million. This represents 2.26% of its overall portfolio holdings.
Number of Shares
9,344,424
Previous 8,188,948
14.11%
Holding current value
$37 Million
Previous $31.9 Million
22.03%
% of portfolio
2.26%
Previous 1.63%
Shares
5 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Black Rock Inc. New York, NY8.14MShares$32.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$21.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$20 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$17.5 Million0.0% of portfolio
-
Mirabella Financial Services LLP London, X03.7MShares$14.7 Million1.48% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $403M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...